Sippel 1999.
| Study characteristics | ||
| Methods | Design: Randomized controlled trial Setting: 2 university‐affiliated primary care clinics, USA Recruitment: Patients approached by research staff in practice |
|
| Participants | 205 adults who smoked, average age 38 years, 62% F, 20 cpd | |
| Interventions | Intervention: participants received advice and cessation information. Additionally, they spent 10 ‐ 15 minutes receiving spirometry, carbon monoxide analysis, interpretation and education Control: participants received advice and cessation information |
|
| Outcomes | Continuous abstinence at 6m Validation: None Secondary outcomes: Quit attempts > 24 hours |
|
| Funding Source | Funded by the American Lung Association of Oregon and the American Academy of Family Practice | |
| Author's declarations of interest | Not reported. | |
| Notes | Strategies: Spirometry + CO monitoring Level: Patient Comparison type: Multi‐component vs. standard care |
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Sequence Generation | High risk | QUOTE: "questionnaires were numbered consecutively at each clinic throughout the study period. Subjects receiving odd‐numbered questionnaires were selected as the intervention group and those receiving even‐numbered questionnaires were selected as the control group..." |
| Allocation concealment | High risk | QUOTE: "the nurses performing patient check‐in were blinded to the questionnaire numbers. As four to six nurses conducted patient check‐ins independently and simultaneously at each clinic, it is unlikely that any given patient would be preferentially enrolled into either study arm". It is unclear how the nurses were blinded to the questionnaire numbers. |
| Blinding of outcome assessors All outcomes | High risk | Smoking status was self‐reported and face‐to‐face was different between the groups |
| Incomplete outcome data All outcomes | Low risk | The overall loss to follow‐up was 15.6% (n = 32/205); 12.6% (n = 13/103) in the intervention group and 18.6% (n = 19/102) were lost to follow‐up at 6 months |